Trulieve Cannabis Corp. quarterly report, Q3 FY2024

Trulieve Cannabis Corp. 10-Q Summary: Q3 2024

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2024. Trulieve Cannabis Corp. is a vertically integrated multi-state cannabis operator with retail, cultivation, and processing facilities across nine U.S. states. As of the reporting date, the company operated 215 dispensaries and 16 cultivation/processing facilities. The company is currently engaged in a significant legal and regulatory campaign regarding the "Smart & Safe Florida" initiative and the federal rescheduling of cannabis.

Key Financial Metrics

Metric (in thousands) Q3 2024 Q3 2023 YTD 2024 YTD 2023
Revenue $284,284 $275,210 $885,345 $842,219
Gross Profit $173,278 $142,946 $528,728 $434,775
Gross Margin 61.0% 51.9% 59.7% 51.6%
Net Loss (GAAP) $(61,856) $(25,843) $(99,015) $(498,346)
Adjusted EBITDA $96,086 $77,738 $308,838 $234,505
Cash & Equivalents $237,666 $201,372 $237,666 $201,372
Short-term Investments $80,179 $0 $80,179 $0
Total Debt (Long-term) $621,372 $615,729 $621,372 $615,729

Note: Total Debt includes Private Placement Notes, Notes Payable, and Construction Finance Liabilities. Figures are in thousands.

Material Changes vs. Prior Period

  • Revenue Growth: Q3 revenue increased 3.3% year-over-year, driven by the opening of 27 new dispensaries (totaling 215) and increased wholesale sales in Maryland and Pennsylvania.
  • Margin Expansion: Gross margin improved significantly to 61.0% (from 51.9% in Q3 2023) due to at-scale cost efficiencies in production facilities.
  • Expense Spike: General and Administrative (G&A) expenses surged 137.7% to $81.9 million, primarily due to $48.4 million in legislative campaign contributions related to the Florida ballot initiative, compared to $0.5 million in the prior year.
  • Tax Provision: The provision for income taxes increased to $47.4 million (Q3 2024) from $36.6 million (Q3 2023), driven by higher gross profit and interest on uncertain tax positions.
  • Cash Flow: Operating cash flow improved dramatically to $240.8 million YTD 2024 (from $70.4 million YTD 2023), largely due to a reduction in net tax payments and improved gross profit.

Guidance, Outlook, and Risks

  • Regulatory Catalysts: The company is heavily focused on the November 5, 2024, Florida election for the "Smart & Safe Florida" initiative (adult-use legalization) and the ongoing federal rescheduling of cannabis to Schedule III.
  • Operational Expansion: Trulieve continues to expand its footprint, recently acquiring Harvest of Ohio and converting licenses to allow adult-use sales in Columbus, Westerville, and Beavercreek.
  • Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting related to information technology and inventory valuation. Remediation efforts are ongoing but not yet concluded.
  • Tax Contingencies: Uncertain tax position liabilities increased to $384.1 million, primarily related to the company's legal challenge of IRC Section 280E (which disallows deductions for cannabis businesses).
  • Liquidity: Management believes existing cash ($237.7M) and short-term investments ($80.2M) are sufficient to meet requirements for the next 12 months.

Investor Verification Checklist

  • Legislative Contributions: Verify the impact of the $48.4M Q3 campaign contribution on future profitability and the likelihood of the Florida ballot initiative passing.
  • Tax Liability Exposure: Assess the risk associated with the $384.1M uncertain tax position liability and the company's reliance on the Section 280E legal challenge.
  • Internal Control Remediation: Monitor progress on remediation of material weaknesses in IT and inventory valuation to ensure future financial reporting reliability.
  • Debt Maturities: Review the $368M private placement notes maturing in October 2026 and the company's refinancing or repayment strategy.
  • Inventory Valuation: Given the material weakness in inventory controls, scrutinize the $220.9M inventory balance for potential write-downs.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.